The major objective of this study is to evaluated osteoporosis prevalence, both on computed tomography (CT) and dual x ray absorptiometry (DXA) in patients included in a fracture liaison service (FLS). The secondary objectives are to evaluate the prevalence of antiosteoporotic treatments indication, of new fractures or mortality; to identify the risk factor for osteoporosis; the study the treatment's observance; to identify the screening threshold to diagnose osteoporosis on CT.
Study Type
OBSERVATIONAL
Enrollment
500
CHRU Nancy
Vandœuvre-lès-Nancy, France
Osteoporosis prevalence on DXA and CT
Time frame: during the evaluation in the fracture liaison service FLS and evry year until 5 years
prevalnce of treatment for osteoporosis
Time frame: during the evaluation in FLS and every year until 5 years
prevalence of new fractures at 1-3 and 5 years
Time frame: during the evaluation in FLS and at 1, 3 and 5 years
identification of osteoporosis risk factors
Time frame: at the inclusion in FLS
definition of the CT threshold for bone fragility in this population;
Time frame: at the inclusion in FLS
study of the correlation dual x ray absorptiometry and computed tomography bone fragility evaluation
Time frame: at the inclusion in FLS
study of the correlation between FRAX score and DXA
Time frame: at the inclusion in FLS
study of the correlation between FRAX score and Trabecular bone score TBS
Time frame: at the inclusion in FLS
study of the correlation between FRAX score and lean mass
Time frame: at the inclusion in FLS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.